Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03419858Phase 1Completed
Phase 1, randomised, double-blind trial (3 arms), sponsored by University of California, San Diego. Primary endpoint: Change in Visual Analog Scale Pain intensity and Unpleasantness ratings up to 3 weeks. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03419858.